[1] |
Molan A, Nosaka K, Hunter M, et al. Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots[J]. Trop Biomed, 2019, 36(4): 898-925.
|
[2] |
Pan M, Lyu CC, Zhao JL, et al. Sixty years (1957—2017) of research on toxoplasmosis in china: an overview[J]. Front Microbiol, 2017, 8: 1825.
doi: 10.3389/fmicb.2017.01825
|
[3] |
Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis[J]. Clin Microbiol Rev, 2012, 25(2): 264-296.
doi: 10.1128/CMR.05013-11
pmid: 22491772
|
[4] |
Elsheikha HM, Marra CM, Zhu XQ. Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis[J]. Clin Microbiol Rev, 2020, 34(1): e00115-e00119.
|
[5] |
Yin K, Xu C, Zhao GH, et al. Epigenetic manipulation of psychiatric behavioral disorders induced by Toxoplasma gondii[J]. Front Cell Infect Microbiol, 2022, 12: 803502.
doi: 10.3389/fcimb.2022.803502
|
[6] |
Hsu PC, Groer M, Beckie T. New findings: depression, suicide, and Toxoplasma gondii infection[J]. J Am Assoc Nurse Pract, 2014, 26(11): 629-637.
doi: 10.1002/2327-6924.12129
|
[7] |
Boillat M, Hammoudi PM, Dogga SK, et al. Neuroinflammation-associated aspecific manipulation of mouse predator fear by Toxoplasma gondii[J]. Cell Rep, 2020, 30(2): 320-334.e6.
doi: 10.1016/j.celrep.2019.12.019
|
[8] |
Hari Dass SA, Vyas A. Toxoplasma gondii infection reduces predator aversion in rats through epigenetic modulation in the host medial amygdala[J]. Mol Ecol, 2014, 23(24): 6114-6122.
doi: 10.1111/mec.2014.23.issue-24
|
[9] |
Syn G, Anderson D, Blackwell JM, et al. Epigenetic dysregulation of host gene expression in Toxoplasma infection with specific reference to dopamine and amyloid pathways[J]. Infect Genet Evol, 2018, 65: 159-162.
doi: 10.1016/j.meegid.2018.07.034
|
[10] |
Holmes MJ, Padgett LR, Bastos MS, et al. m6A RNA methylation facilitates pre-mRNA 3'-end formation and is essential for viability of Toxoplasma gondii[J]. PLoS Pathog, 2021, 17(7): e1009335.
doi: 10.1371/journal.ppat.1009335
|
[11] |
Farhat DC, Bowler MW, Communie G, et al. A plant-like mechanism coupling m6A reading to polyadenylation safeguards transcriptome integrity and developmental gene partitioning in Toxoplasma[J]. eLife, 2021, 10: e68312.
doi: 10.7554/eLife.68312
|
[12] |
Baumgarten S, Bryant JM, Sinha A, et al. Transcriptome-wide dynamics of extensive m6A mRNA methylation during Plasmodium falciparum blood-stage development[J]. Nat Microbiol, 2019, 4(12): 2246-2259.
doi: 10.1038/s41564-019-0521-7
pmid: 31384004
|
[13] |
Zhang N, Ding CH, Zuo YX, et al. N6-methyladenosine and neurological diseases[J]. Mol Neurobiol, 2022, 59(3): 1925-1937.
doi: 10.1007/s12035-022-02739-0
pmid: 35032318
|
[14] |
Imanishi M. Mechanisms and strategies for determining m6A RNA modification sites by natural and engineered m6A effector proteins[J]. Chem Asian J, 2022, 17(16): e202200367.
|
[15] |
Xiao S, Cao S, Huang QT, et al. The RNA N6-methyladenosine modification landscape of human fetal tissues[J]. Nat Cell Biol, 2019, 21(5): 651-661.
doi: 10.1038/s41556-019-0315-4
|
[16] |
Oerum S, Meynier V, Catala M, et al. A comprehensive review of m6A/m6Am RNA methyltransferase structures[J]. Nucleic Acids Res, 2021, 49(13): 7239-7255.
doi: 10.1093/nar/gkab378
pmid: 34023900
|
[17] |
Zhao GH, Zhang LX, Dai LS, et al. Development of Toxoplasma gondii Chinese Ⅰ genotype wh6 strain in cat intestinal epithelial cells[J]. Korean J Parasitol, 2022, 60(4): 241-246.
doi: 10.3347/kjp.2022.60.4.241
|
[18] |
Zhao GH, Dai LS, Zhu JJ, et al. Development research of Toxoplasma gondii Chinese Ⅲ genotype strain isolated from humans in the definitive host[J]. J Pathog Biol, 2022, 17(2): 174-179. (in Chinese)
|
|
(赵桂华, 代莉莎, 朱进进, 等. 人源中国Ⅲ型刚地弓形虫分离株在终末宿主内的发育研究[J]. 中国病原生物学杂志, 2022, 17(2): 174-179.)
|
[19] |
Lorenz DA, Sathe S, Einstein JM, et al. Direct RNA sequencing enables m6A detection in endogenous transcript isoforms at base-specific resolution[J]. RNA, 2020, 26(1): 19-28.
doi: 10.1261/rna.072785.119
|
[20] |
Liu HB, Liu XJ, Zhang SM, et al. Systematic identification and annotation of human methylation marks based on bisulfite sequencing methylomes reveals distinct roles of cell type-specific hypomethylation in the regulation of cell identity genes[J]. Nucleic Acids Res, 2016, 44(1): 75-94.
doi: 10.1093/nar/gkv1332
pmid: 26635396
|
[21] |
Yu GC, Wang LG, Han YY, et al. clusterProfiler: an R package for comparing biological themes among gene clusters[J]. OMICS, 2012, 16(5): 284-287.
doi: 10.1089/omi.2011.0118
pmid: 22455463
|
[22] |
Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles[J]. Proc Natl Acad Sci USA, 2005, 102(43): 15545-15550.
doi: 10.1073/pnas.0506580102
pmid: 16199517
|
[23] |
Vignon M, Bastide A, Attina A, et al. Multiplexed LC-MS/MS quantification of salivary RNA modifications in periodontitis[J]. J Periodontal Res, 2023, 58(5): 959-967.
doi: 10.1111/jre.v58.5
|
[24] |
Zhang Z, Wang Q, Zhang MM, et al. Comprehensive analysis of the transcriptome-wide m6A methylome in colorectal cancer by MeRIP sequencing[J]. Epigenetics, 2021, 16(4): 425-435.
doi: 10.1080/15592294.2020.1805684
|
[25] |
Krusnauskas R, Stakaitis R, Steponaitis G, et al. Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq[J]. Epigenetics, 2023, 18(1): 2163365.
doi: 10.1080/15592294.2022.2163365
|
[26] |
Sendinc E, Shi Y. RNA m6A methylation across the transcriptome[J]. Mol Cell, 2023, 83(3): 428-441.
doi: 10.1016/j.molcel.2023.01.006
pmid: 36736310
|
[27] |
He HY, Hu L. Cysteine-rich intestinal protein 1 enhances the progression of hepatocellular carcinoma via Ras signaling[J]. Kaohsiung J Med Sci, 2022, 38(1): 49-58.
doi: 10.1002/kjm2.v38.1
|
[28] |
Imp BM, Rubin LH, Tien PC, et al. Monocyte activation is associated with worse cognitive performance in HIV-infected women with virologic suppression[J]. J Infect Dis, 2017, 215(1): 114-121.
doi: 10.1093/infdis/jiw506
pmid: 27789726
|
[29] |
Bichsel SJ, Tamaskovic R, Stegert MR, et al. Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein[J]. J Biol Chem, 2004, 279(34): 35228-35235.
doi: 10.1074/jbc.M404542200
pmid: 15197186
|
[30] |
Hergovich A. MOB control: reviewing a conserved family of kinase regulators[J]. Cell Signal, 2011, 23(9): 1433-1440.
doi: 10.1016/j.cellsig.2011.04.007
pmid: 21539912
|
[31] |
Hong AW, Meng ZP, Guan KL. The Hippo pathway in intestinal regeneration and disease[J]. Nat Rev Gastroenterol Hepatol, 2016, 13(6): 324-337.
doi: 10.1038/nrgastro.2016.59
pmid: 27147489
|
[32] |
Ewing RM, Chu P, Elisma F, et al. Large-scale mapping of human protein-protein interactions by mass spectrometry[J]. Mol Syst Biol, 2007, 3: 89.
pmid: 17353931
|
[33] |
Hutloff A, Dittrich AM, Beier KC, et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28[J]. Nature, 1999, 397(6716): 263-266.
doi: 10.1038/16717
|
[34] |
Simpson TR, Quezada SA, Allison JP. Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)[J]. Curr Opin Immunol, 2010, 22(3): 326-332.
doi: 10.1016/j.coi.2010.01.001
pmid: 20116985
|
[35] |
Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses[J]. Annu Rev Immunol, 2002, 20: 29-53.
pmid: 11861596
|
[36] |
Villegas EN, Lieberman LA, Mason N, et al. A role for inducible costimulator protein in the CD28-independent mechanism of resistance to Toxoplasma gondii[J]. J Immunol, 2002, 169(2): 937-943.
pmid: 12097399
|
[37] |
Wilson EH, Zaph C, Mohrs M, et al. B7RP-1-ICOS interactions are required for optimal infection-induced expansion of CD4+ Th1 and Th2 responses[J]. J Immunol, 2006, 177(4): 2365-2372.
pmid: 16887998
|
[38] |
O’Brien CA, Batista SJ, Still KM, et al. IL-10 and ICOS differentially regulate T cell responses in the brain during chronic Toxoplasma gondii infection[J]. J Immunol, 2019, 202(6): 1755-1766.
doi: 10.4049/jimmunol.1801229
|
[39] |
Suzuki Y, Lutshumba J, Chen KC, et al. IFN-γ production by brain-resident cells activates cerebral mRNA expression of a wide spectrum of molecules critical for both innate and T cell-mediated protective immunity to control reactivation of chronic infection with Toxoplasma gondii[J]. Front Cell Infect Microbiol, 2023, 13: 1110508.
doi: 10.3389/fcimb.2023.1110508
|